Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico

BioFactors

Volumn 41, Issue 4, 2015, Pages 242-251

  Jhong, Chien Hung ^a   Riyaphan, Jirawat ^a   Lin, Shih Hung ^a   Chia, Yi Chen ^b   Weng, Ching Feng ^a  

^a NATIONAL DONG HWA UNIVERSITY   (Taiwan)

^b TAJEN UNIVERSITY   (Taiwan)

Author keywords

Diabetes mellitus; Hyperglycemia; Molecular docking; amylase; glucosidase

Indexed keywords

16 HYDROXY CLERODA 3,13 DINE 16,15 OLIDE; ACARBOSE; ACTINODAPHNINE; ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; AMYLASE; AMYLASE INHIBITOR; ANTIDIABETIC AGENT; ANTROQUINONOL; BEHENYL ALCOHOL; BERBERINE; CATECHIN; CURCUMIN; NATURAL PRODUCT; QUERCETIN; RUTOSIDE; TETRACOSANOL; UNCLASSIFIED DRUG; BIOLOGICAL PRODUCT; DITERPENE; GLYCOSIDASE INHIBITOR; RECOMBINANT PROTEIN;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVITY; HYPERGLYCEMIA; IC50; MOLECULAR DOCKING; MOLECULAR LIBRARY; PRIORITY JOURNAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; COMPUTER INTERFACE; HIGH THROUGHPUT SCREENING; HUMAN;

ACARBOSE; ALPHA-AMYLASES; ALPHA-GLUCOSIDASES; BERBERINE; BIOLOGICAL PRODUCTS; CURCUMIN; DITERPENES; GLYCOSIDE HYDROLASE INHIBITORS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; HYPOGLYCEMIC AGENTS; MOLECULAR DOCKING SIMULATION; QUERCETIN; RECOMBINANT PROTEINS; USER-COMPUTER INTERFACE;

EID: 84939572208     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1219     Document Type: Article

References (41)

1. WHO. (2013) Screening for Type 2 Diabetes, Report of a World Health Organization and International Diabetes Federation Meeting. Department of Noncommunicable Disease Manangement, Geneva, Switzerland, pp. 1-41.
2. Lin, C. C., Li, C. I., Hsiao, C. Y., Liu, C. S., Yang, S. Y., et al. (2013) Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study. BMC Public Health 13, 1-10.
3. Adi, S. and Andrea, G. G. (2012) Type 1 diabetes mellitus: an overview. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. Department of Pediatrics, Division of Pediatric Endocrinology, University of California, San Francisco CA. DOI: 10.1016/B978-0-12-385083-6.15001-6.
4. Nair, S. S., Kavrekar, V., and Mishra, A. (2013) In vitro studies on alpha amylase and alpha glucosidase inhibitory activities of selected plant extracts. Eur. J. Exp. Biol. 3, 128-132.
5. Yee, H. S. and Fong, N. T. (1996) A review of the safety and efficacy of acarbose in diabetes mellitus. Pharmacotherapy 16, 792-805.
6. van de Laar, F. A. (2008) Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes. Vasc. Health Risk Manage. 4, 1189-1195.
7. Kitchen, D. H., Furr, D. B., and Bajorath, J. R. J. (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat. Rev. Drug Discov. 3, 935-949.
8. Gilson, M. K. and Zhou, H. X. (2007) Calculation of protein-ligand binding affinities. Annu. Rev. Biophys. Biomol. Struct. 36, 21-42.
9. Xiaoyu Qing, X. Y. L., Raeymaeker J. D., Jeremy, R. H. T., Kam, Y. J. Z., Marc, D. M., et al., (2014) Pharmacophore modeling: advances, limitations, and current utility in drug discovery. J. Receptor Ligand Channel Res. 7, 81-92.
10. Yang, S. Y. (2010) Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov. Today 15, 444-450.
11. Mukesh, K. R. B. (2011) Molecular docking: a review. IJRAP 2, 1746-1751.
12. Huang, Y. R. W. K. -F., Chang, E.-C., Chou, T.-L., and Wang, A. H. J. (2008) A conserved hydrogen-bond network in the catalytic centre of animal glutaminyl cyclases is critical for catalysis. Biochem. J., 411, 181-190.
13. Brayer, Y. L. G. and Withers S. G. (1995) The structure of human pancreatic a-amylase at 1.8 A° resolution and comparisons with related enzymes. Protein Sci., 4, 1730-1742.
14. Tadera, K., Yuji, M., Kouta, T., and Tomoko, M., (2006) Inhibition of α-glucosidase and α-amylase by flavonoids. J. Nutr. Sci. Vitaminol., 52, 149-153.
15. Mogale, M. A., Lebelo, S. L., Thovhogi, N., de Freitas, A. N., and Shai, L. J. (2011) α-amylase and α-glucosidase inhibitory effects of Sclerocarya birrea [(A. Rich.) Hochst.] subspecies caffra (Sond) Kokwaro (Anacardiaceae) stem-bark extracts. Afr. J. Biotechnol., 10, 15033-15039.
16. Venkatachalam, C. M., Jiang, X., Oldfield, T., and Waldman, M. (2003) LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J. Mol. Graph. Model. 21, 289-307.
17. Wu, F., Xu, T., He, G., Ouyang, L., Han, B., et al. (2012) Discovery of novel focal adhesion kinase inhibitors using a hybrid protocol of virtual screening approach based on multicomplex-based pharmacophore and molecular docking. Int. J. Mol. Sci., 13, 15668-15678.
18. World Health Organization. (2012) Top 10 leading causes of death in the world 2000 and 2012. Available at: http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed on May, 2014.
19. Wang, Z. D. H., Zhang, C., Tang, Z., He, Y., Zhang, Q., et al. (2014) Biological evaluation and 3D-QSAR studies of curcumin analogues as aldehyde dehydrogenase 1 inhibitors. J. Mol. Sci., 15, 8795-8807.
20. De Luca, J. M. O. C. (2008) Inflammation and insulin resistance. FEBS Lett. 582, 97-105.
21. Hanefeld, F. S. M. (2008) Acarbose: oral antidiabetes drug with additional cardiovascular benefits. Expert Rev. Cardiovasc. Ther. 6, 153-163.
22. Nakano, I. I. T., Seo, M., Takahashi, S., Komoda, T., and Katayama, S. (2009) Acarbose attenuates postprandial hyperlipidemia: investigation in an intestinal absortive cell model. Metabolism 58, 583-585.
23. Yan, G. Z. J., Pan, J., and Wang, Y. (2014) α-glucosidase inhibition by luteolin: kinetics, interaction and molecular docking. Int. J. Biol. Macromol. 64, 213-223.
24. Curic, Y. W. S., Shan, B., Schaaf, C., Utpadel, D., Lange, M., et al. (2013) Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas. J. Neurooncol. 113, 385-396.
25. Wang, Z. D. H., Zhang, C., Tang, Z., He, Y., Zhang, Q., et al. (2014) Biological evaluation and 3D-QSAR studies of curcumin analogues as aldehyde dehydrogenase 1 inhibitors. J. Mol. Sci. 15, 8795-8807.
26. Jong-Sang, K., Chong-Suk, K., and Kun Ho, S. (2000) Inhibition of alpha-glucosidase and amylase by luteotin, a flavonoid. Biosci. Biotechnol. Biochem. 64, 2458-2461.
27. Zhang, M.F D.-W., Gao, S.-H. Liu, and, J.-L. (2013) Curcumin and diabetes: a systematic review. Evid. Based Complement. Alternat. Med. 2013, 1-16.
28. Stefanska, B. (2012) Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus-insights into its mechanism of action. Br. J. Pharmacol. 166, 2209-2211.
29. Chiang, S. C. L. P. C., Pan, S. L., Kuo, C. H., Tsai, I.-L., Kuo, M. T., et al. (2010) Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways. Biochem. Pharmacol. 79, 167-171.
30. Wang, Y. L. R. and Wang, S. (2003) Comparative evaluation of 11 scoring functions for molecular docking. J. Med. Chem. 46, 2287-2303.
31. Blundell, B. L. S. T. L., Montalvão, R. W., Brewerton, S., Chelliah, V., Worth, C. L., et al. (2006) Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery. Philos. Trans. R Soc. Lond. B Biol. Sci. 361, 413-423.
32. Sunand, D. O. S. H. (2010) Structure-based drug metabolism predictions for drug design. Chem. Biol. Drug Des. 75, 3-17.
33. Brindis, R. R. F., Bye, R., Gonzalez-Andrade, M., and Mata, R. (2011) (Z)-3-butylidenephthalide from Ligusticum porter, an α-glucosidase inhibitor. J. Nat. Prod. 74, 314-320.
34. Yin, H. X. J. and Ye, J. (2008) Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 57, 712-717.
35. Daisy, K. B. P., Rajalakshmi, M., Eliza, J., and Selvaraj, J. (2010) Insulin mimetic impact of catechin isolated from Cassia fistula on the glucose oxidation and molecular mechanisms of glucose uptake on streptozotocin-induced diabetic Wistar rats. Phytomedicine 17, 28-36.
36. Kumar, R. G. A. (2008) Quercetin protects against acute immobilization stress-induced behaviors and biochemical alterations in mice. J. Med. Food 11, 469-473.
37. Fernandes, E. L. B. N. A. A. H., Okoshi, K., Okoshi, M. P., Muzio, B. P. D., Guimarães, J. F. C., et al. (2010) Influence of rutin treatment on biochemical alterations in experimental diabetes. Biomed. Pharmacother. 64, 214-219.
38. Yang, S. C. C. H. L., Lin, K. Y., Wang, M. T., Chen, Y. C., et al. (2011) Antioxidant activities of aqueous leaf extracts of Toona sinensis on free radical-induced endothelial cell damage. J. Ethnopharmacol. 137, 669-680.
39. Borges de Melo, A. D. S. G. E. and Carvalho, I. (2006) α- and β- glucosidase inhibitors: chemical structure and biological activity. Tetrahedron 62, 10277-10302.
40. Kim, C. S. K. J. S. and Son, K. H. (2000) Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Biosci. Biotechnol. Biochem. 64, 2458-2461.
41. Kumar, S. N. S., Kumar, V., and Prakash, O. (2011) α-Glucosidase inhibitors from plants: a natural approach to treat diabetes. Pharmacogn. Rev. 5, 19-29.